Services-Commercial Physical & Biological Research · DE · CIK 1478242
IQVIA provides clinical research, commercial insights, and healthcare intelligence to life sciences and healthcare industries
Comparable business profile · signals at a glance
In the 90 days to Dec 18, 2025: 2 sold $21.5M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 2025 | Bousbib AriSee Remarks | Sell | 36,564 | $222.43 | $8.1M |
| Oct 29, 2025 | Bousbib AriSee Remarks | Sell | 26,128 | $221.31 | $5.8M |
| Oct 29, 2025 | Bousbib AriSee Remarks | Sell | 13,741 | $219.29 | $3.0M |
| Oct 29, 2025 | Bousbib AriSee Remarks | Sell | 7,315 | $218.32 | $1.6M |
| Oct 29, 2025 | Bousbib AriSee Remarks | Sell | 4,600 | $220.11 | $1.0M |
| Oct 29, 2025 | Bousbib AriSee Remarks | Sell | 3,973 | $221.97 | $882K |
| Oct 29, 2025 | Sherbet EricSee Remarks | Sell | 4,000 | $219.70 | $879K |
| Oct 29, 2025 | Bousbib AriSee Remarks | Sell | 800 | $217.58 | $174K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Coverage (30d): 10 reputable articles.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗